To the Editors-It is striking that Austad et al 1 found no association between an institution's grade on the American Medical Student Association (AMSA) conflict-of-interest (COI) policy scorecard and its trainees' behavior and attitudes toward industry-findings which contradict those of contemporaneous studies. For example, King et al found that graduates of medical schools that banned industry gifts were less likely to prescribe newly marketed "me-too" psychotropic drugs than were graduates of programs without such policies.
To the Editors-It is striking that Austad et al 1 found no association between an institution's grade on the American Medical Student Association (AMSA) conflict-of-interest (COI) policy scorecard and its trainees' behavior and attitudes toward industry-findings which contradict those of contemporaneous studies. For example, King et al found that graduates of medical schools that banned industry gifts were less likely to prescribe newly marketed "me-too" psychotropic drugs than were graduates of programs without such policies. 2 And Epstein et al found that "rates of prescribing heavily promoted, brand reformulated, and brand antidepressants in 2009 were lower among post-COI graduates than pre-COI graduates at all levels of COI restrictiveness. 3 Of note, Austad et al did show that a majority of medical trainees are critical of the pharmaceutical industry's marketing strategies, up from 2005, when Sierles et al found that fewer than a quarter of third-year medical students supported separation between the pharmaceutical industry and trainees. 4 To make progress in enhancing objectivity and integrity in medical education, we must take a multifaceted approach, including both adoption and meaningful enforcement of strong conflict-of-interest policies, along with improved education of trainees and faculty on the clinical consequences of industry influence.
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